
|Articles|December 1, 2003
Promising Alternatives
Las Vegas - New pharmaceuticals including calcineurin inhibitors represent viable alternatives to traditional treatments for eczematous dermatoses, according to Joseph F. Fowler, Jr., M.D. He is a clinical professor of dermatology in Kentucky's University of Louisville School of Medicine, and estimated he has treated several thousand dermatitis patients.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















